New mechanisms of pulmonary fibrosis

Chest

Volumn 136, Issue 5, 2009, Pages 1364-1370

  Strieter, Robert M ^a   Mehrad, Borna ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BASEMENT MEMBRANE; EPITHELIZATION; FIBROSING ALVEOLITIS; HEMATOPOIETIC STEM CELL; HUMAN; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG CAPILLARY; LUNG FIBROSIS; LUNG INJURY; LUNG PARENCHYMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE STRUCTURE;

EID: 70449440734     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0510     Document Type: Article

References (61)

1. Crystal RG, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85:769-788
2. Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982; 37:1-10
3. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134:136-151 (Pubitemid 32096342)
4. Weibel ER. Morphological basis of alveolar-capillary gas exchange. Physiol Rev 1973; 53:419-495
5. Clark RA. Basics of cutaneous wound repair. J Dermatol Surg Oncol 1993; 19:693-706
6. Davidson JM. Wound repair. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York, NY: Raven Press, 1992
7. Keane MP, Belperio JA, Henson PM, et al. Inflammation, injury, and repair. In: Mason RJ, Broaddus VC, Murray JF, et al, eds. Textbook of respiratory medicine. 4th ed. Philadelphia, PA: Elsevier Saunders, 2005; 449-490
8. Wallace WAH, Fitch PM, Simpson JA, et al. Inflammation-associated remodelling and fibrosis in the lung: a process and an end point. Int J Exp Pathol 2007; 88:103-110
9. Basset F, Ferrans VJ, Soler P, et al. Intraluminal fibrosis in interstitial lung disorders. Am J Pathol 1986; 122:443-461 (Pubitemid 16017665)
10. Corrin B, Dewar A, Rodriguez-Roisin R, et al. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985; 147:107-119 (Pubitemid 16220638)
11. Kuhn C III, Boldt J, King TE Jr, et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989; 140:1693-1703 (Pubitemid 20041056)
12. McDonald JA. Idiopathic pulmonary fibrosis: a paradigm for lung injury and repair. Chest 1991; 99(suppl):87S-93S
13. Strieter RM, Gomperts BN, Keane MP. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 2007; 117: 549-556 (Pubitemid 46348509)
14. Strieter RM. Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel. Chest 2005; 128(suppl):526S-532S
15. Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006; 174:654-658
16. Wright RR. Elastic tissue of normal and emphysematous lungs: a tridimensional histologic study: Am J Pathol 1961; 39:355-367
17. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100:768-776 (Pubitemid 27371693)
18. Lee CG, Cho SJ, Kang MJ, et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J Exp Med 2004; 200:377-389
19. Kolb M, Margetts PJ, Anthony DC, et al. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001; 107:1529-1536 (Pubitemid 32574639)
20. Antoniades HN, Bravo MA, Avila RE, et al. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990; 86:1055-1064 (Pubitemid 20370408)
21. Aston C, Jagirdar J, Lee TC, et al. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151:1597-1603
22. Hsu E, Feghali-Bostwick CA. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol 2008; 172:1580-1590 (Pubitemid 351793351)
23. Martinet Y, Rom WN, Grotendorst GR, et al. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med 1987; 317:202-209 (Pubitemid 17103101)
24. Nagaoka I, Trapnell BC, Crystal RG. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis. J Clin Invest 1990; 85:2023-2027 (Pubitemid 20192983)
25. Uh ST, Inoue Y, King TE Jr, et al. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158:1626-1635 (Pubitemid 28536630)
26. Vanhee D, Gosset P, Wallaert B, et al. Mechanisms of fibrosis in coal workers' pneumoconiosis: increased production of plateletderived growth factor, insulin-like growth factor type I, and transforming growth factor β and relationship to disease severity: Am J Respir Crit Care Med 1994; 150:1049-1055 (Pubitemid 24318034)
27. Marchand-Adam S, Marchal J, Cohen M, et al. Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 1156-1161 (Pubitemid 37421832)
28. Abdollahi A, Li M, Ping G, et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 2005; 201:925-935 (Pubitemid 40524462)
29. Hardie WD, Davidson C, Ikegami M, et al. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-α-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1217-L1225
30. Ishii Y, Fujimoto S, Fukuda T. Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 2006; 174:550-556 (Pubitemid 44330548)
31. Hancock A, Armstrong L, Gama R, et al. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998; 18:60-65 (Pubitemid 128355347)
32. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103:779-788 (Pubitemid 29152623)
33. Belperio JA, Dy M, Burdick MD, et al. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2002; 27:419-427
34. Jakubzick C, Choi ES, Joshi BH, et al. Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells. J Immunol 2003; 171:2684-2693 (Pubitemid 37025582)
35. Kolodsick JE, Toews GB, Jakubzick C, et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J Immunol 2004; 172:4068-4076 (Pubitemid 38375218)
36. Kaviratne M, Hesse M, Leusink M, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent. J Immunol 2004; 173:4020-4029 (Pubitemid 39280766)
37. Lee CG, Homer RJ, Zhu Z, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1. J Exp Med 2001; 194:809-821 (Pubitemid 32983016)
38. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A 2002; 99:6292-6297 (Pubitemid 34493305)
39. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 2006; 176:5735-5739
40. Attili AK, Kazerooni EA, Gross BH, et al. Thoracic lymph node enlargement in usual interstitial pneumonitis and nonspecific-interstitial pneumonitis: prevalence, correlation with disease activity and temporal evolution. J Thorac Imaging 2006; 21: 288-292
41. Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124:1215-1223
42. Gomperts BN, Strieter RM. Fibrocytes in lung disease. J Leukoc Biol 2007
43. Kasai H, Allen JT, Mason RM, et al. TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res 2005; 6:56 (Pubitemid 41410179)
44. Yao HW, Xie QM, Chen JQ, et al. TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci 2004; 76:29-37 (Pubitemid 39389169)
45. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005; 166:1321-1332 (Pubitemid 40586504)
46. Kim KK, Wei Y, Szekeres C, et al. Epithelial cell α3β1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 2009; 119:213-224
47. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 2006; 103:13180-13185
48. Yamada M, Kuwano K, Maeyama T, et al. Dualimmunohistochemistry provides little evidence for epithelialmesenchymal transition in pulmonary fibrosis. Histochem Cell Biol 2008; 129:453-462
49. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1:71-81
50. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438-446 (Pubitemid 39071616)
51. Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36:598-606 (Pubitemid 38316817)
52. Epperly MW, Guo H, Gretton JE, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003; 29:213-224 (Pubitemid 36936649)
53. Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004; 113:243-252 (Pubitemid 38544209)
54. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166:7556-7562 (Pubitemid 32525636)
55. Metz CN. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003; 60:1342-1350
56. Hong KM, Belperio JB, Keane MP, et al. Differentiation of human circulating fibrocytesas mediated by transforming growth factor-β and peroxisome proliferator activated receptor-A-γ. J Biol Chem 2007; 282:22910-22920
57. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171:380-389 (Pubitemid 36745311)
58. Moore BB, Kolodsick JE, Thannickal VJ, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005; 166:675-684
59. Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 2007; 353:104-108 (Pubitemid 44958347)
60. Andersson-Sjoland A, de Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-2140
61. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:588-594